A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. 1998

F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
INSERM U372, Marseille, France.

Studies analysing human immunodeficiency virus type 1 replication in primary cells have demonstrated that Vpr, although dispensable, plays a role along with the matrix (MA) protein in allowing nuclear localization of viral preintegration complexes in non-dividing monocyte-derived macrophages (MDMs). In the current study, experimental infection conditions to analyse the role of Vpr, independently of MA, during infection of PHA/IL-2-stimulated peripheral blood mononuclear cells (PBMC) were designed. It was shown that the absence of Vpr results in a subtle effect on virus production in long-term infection. PCR analysis of the steps of virus retrotranscription during a single cycle of replication in stimulated PBMC revealed that the absence of Vpr alone correlates with an impairment in the nuclear localization of viral DNA. Our data indicate that Vpr is involved in the virus life-cycle during infection of dividing PBMC, presumably as it is during infection of MDMs.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016336 Gene Products, vpr Trans-acting proteins which accelerate retroviral virus replication. The vpr proteins act in trans to increase the levels of specified proteins. vpr is short for viral protein R, where R is undefined. vpr Gene Products,vpr Protein,Gene Product, vpr,Viral Protein R,Viral Protein R (vpr),Protein R, Viral,vpr Gene Product
D054325 vpr Gene Products, Human Immunodeficiency Virus Proteins encoded by the VPR GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV vpr Gene Product,Viral Protein R, HIV,vpr Protein, Human Immunodeficiency Virus

Related Publications

F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
April 1999, The Journal of general virology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
February 2011, Transfusion,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
April 1993, The Journal of infectious diseases,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
September 2001, The Journal of infectious diseases,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
March 1995, Clinical and diagnostic laboratory immunology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
September 1995, Journal of virology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
January 1992, Archives of virology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
February 1995, Virology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
February 1995, Journal of virology,
F Rey, and M BouHamdan, and J M Navarro, and I Agostini, and K Willetts, and M Bouyac, and C Tamalet, and B Spire, and R Vigne, and J Sire
November 1993, The Journal of infectious diseases,
Copied contents to your clipboard!